nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—CYP19A1—osteoporosis	0.288	1	CbGaD
Nandrolone decanoate—AR—Ergocalciferol—osteoporosis	0.125	0.475	CbGbCtD
Nandrolone decanoate—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.0998	0.258	CrCrCtD
Nandrolone decanoate—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.0974	0.252	CrCrCtD
Nandrolone decanoate—CYP19A1—Raloxifene—osteoporosis	0.073	0.278	CbGbCtD
Nandrolone decanoate—AR—Estradiol—osteoporosis	0.0648	0.247	CbGbCtD
Nandrolone decanoate—Etonogestrel—Ethinyl Estradiol—osteoporosis	0.0495	0.128	CrCrCtD
Nandrolone decanoate—Norelgestromin—Ethinyl Estradiol—osteoporosis	0.0468	0.121	CrCrCtD
Nandrolone decanoate—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.0387	0.1	CrCrCtD
Nandrolone decanoate—Norethindrone—Ethinyl Estradiol—osteoporosis	0.0311	0.0804	CrCrCtD
Nandrolone decanoate—Testosterone—Estradiol—osteoporosis	0.0233	0.0602	CrCrCtD
Nandrolone decanoate—Haemoglobin increased—Calcitriol—osteoporosis	0.00558	0.123	CcSEcCtD
Nandrolone decanoate—Benign prostatic hyperplasia—Risedronate—osteoporosis	0.0034	0.075	CcSEcCtD
Nandrolone decanoate—Water retention—Conjugated Estrogens—osteoporosis	0.00217	0.0479	CcSEcCtD
Nandrolone decanoate—Local reaction—Ibandronate—osteoporosis	0.00129	0.0285	CcSEcCtD
Nandrolone decanoate—Hirsutism—Estropipate—osteoporosis	0.00128	0.0283	CcSEcCtD
Nandrolone decanoate—Local reaction—Ethinyl Estradiol—osteoporosis	0.00109	0.0241	CcSEcCtD
Nandrolone decanoate—MAOB—Alpha-synuclein signaling—PARK7—osteoporosis	0.00106	0.0751	CbGpPWpGaD
Nandrolone decanoate—Local reaction—Pamidronate—osteoporosis	0.00101	0.0223	CcSEcCtD
Nandrolone decanoate—Local reaction—Zoledronate—osteoporosis	0.000924	0.0204	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Estropipate—osteoporosis	0.000848	0.0187	CcSEcCtD
Nandrolone decanoate—Hirsutism—Conjugated Estrogens—osteoporosis	0.000847	0.0187	CcSEcCtD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—SHBG—osteoporosis	0.000846	0.06	CbGpPWpGaD
Nandrolone decanoate—Acne—Ethinyl Estradiol—osteoporosis	0.000718	0.0159	CcSEcCtD
Nandrolone decanoate—Fluid retention—Estropipate—osteoporosis	0.000707	0.0156	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Ethinyl Estradiol—osteoporosis	0.000687	0.0152	CcSEcCtD
Nandrolone decanoate—Hirsutism—Estradiol—osteoporosis	0.000678	0.015	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Estropipate—osteoporosis	0.000619	0.0137	CcSEcCtD
Nandrolone decanoate—CYP19A1—Endogenous sterols—CYP27A1—osteoporosis	0.000587	0.0416	CbGpPWpGaD
Nandrolone decanoate—Fluid retention—Ethinyl Estradiol—osteoporosis	0.000573	0.0127	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Conjugated Estrogens—osteoporosis	0.00056	0.0124	CcSEcCtD
Nandrolone decanoate—Libido decreased—Calcitriol—osteoporosis	0.000548	0.0121	CcSEcCtD
Nandrolone decanoate—Irritability—Estropipate—osteoporosis	0.000516	0.0114	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Calcitriol—osteoporosis	0.000504	0.0111	CcSEcCtD
Nandrolone decanoate—Libido decreased—Ethinyl Estradiol—osteoporosis	0.000473	0.0105	CcSEcCtD
Nandrolone decanoate—Acne—Estradiol—osteoporosis	0.000468	0.0104	CcSEcCtD
Nandrolone decanoate—Oedema—Calcium Acetate—osteoporosis	0.000468	0.0103	CcSEcCtD
Nandrolone decanoate—Fluid retention—Conjugated Estrogens—osteoporosis	0.000467	0.0103	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Pamidronate—osteoporosis	0.000465	0.0103	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Estradiol—osteoporosis	0.000448	0.00991	CcSEcCtD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—GSN—osteoporosis	0.000439	0.0311	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Ergocalciferol—osteoporosis	0.000437	0.00967	CcSEcCtD
Nandrolone decanoate—Disturbance in sexual arousal—Ethinyl Estradiol—osteoporosis	0.000435	0.00961	CcSEcCtD
Nandrolone decanoate—Irritability—Ethinyl Estradiol—osteoporosis	0.000418	0.00925	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Conjugated Estrogens—osteoporosis	0.000409	0.00904	CcSEcCtD
Nandrolone decanoate—Nandrolone phenpropionate—CYP19A1—osteoporosis	0.000393	0.132	CrCbGaD
Nandrolone decanoate—Etonogestrel—SHBG—osteoporosis	0.000382	0.128	CrCbGaD
Nandrolone decanoate—Fluid retention—Estradiol—osteoporosis	0.000374	0.00827	CcSEcCtD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000361	0.0256	CbGpPWpGaD
Nandrolone decanoate—Gynaecomastia—Estradiol—osteoporosis	0.000353	0.00779	CcSEcCtD
Nandrolone decanoate—Ethynodiol—ESR1—osteoporosis	0.00035	0.118	CrCbGaD
Nandrolone decanoate—Irritability—Conjugated Estrogens—osteoporosis	0.000341	0.00754	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Estropipate—osteoporosis	0.000337	0.00745	CcSEcCtD
Nandrolone decanoate—Pruritus—Calcium Acetate—osteoporosis	0.000331	0.00732	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Estradiol—osteoporosis	0.000327	0.00723	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—PARK7—osteoporosis	0.000324	0.023	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Ibandronate—osteoporosis	0.000323	0.00715	CcSEcCtD
Nandrolone decanoate—Libido decreased—Estradiol—osteoporosis	0.000308	0.00682	CcSEcCtD
Nandrolone decanoate—Norgestimate—ESR1—osteoporosis	0.000298	0.1	CrCbGaD
Nandrolone decanoate—MAOB—Tryptophan metabolism—CYP19A1—osteoporosis	0.000289	0.0205	CbGpPWpGaD
Nandrolone decanoate—Disturbance in sexual arousal—Estradiol—osteoporosis	0.000284	0.00627	CcSEcCtD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—BGLAP—osteoporosis	0.000278	0.0197	CbGpPWpGaD
Nandrolone decanoate—Nausea—Calcium Acetate—osteoporosis	0.000278	0.00615	CcSEcCtD
Nandrolone decanoate—Irritability—Estradiol—osteoporosis	0.000273	0.00603	CcSEcCtD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000273	0.0193	CbGpPWpGaD
Nandrolone decanoate—Levonorgestrel—SHBG—osteoporosis	0.00027	0.0909	CrCbGaD
Nandrolone decanoate—Hypertension—Ibandronate—osteoporosis	0.00027	0.00596	CcSEcCtD
Nandrolone decanoate—CYP19A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000269	0.0191	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Risedronate—osteoporosis	0.000267	0.00589	CcSEcCtD
Nandrolone decanoate—Oedema—Estropipate—osteoporosis	0.000266	0.00588	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—ESR2—osteoporosis	0.000264	0.0187	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Calcitriol—osteoporosis	0.000264	0.00584	CcSEcCtD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—ESR2—osteoporosis	0.000261	0.0185	CbGpPWpGaD
Nandrolone decanoate—Etonogestrel—ESR1—osteoporosis	0.000258	0.0867	CrCbGaD
Nandrolone decanoate—MAOA—Serotonin Transporter Activity—IL1B—osteoporosis	0.000254	0.018	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Pamidronate—osteoporosis	0.000253	0.0056	CcSEcCtD
Nandrolone decanoate—Nausea—Ergocalciferol—osteoporosis	0.000246	0.00543	CcSEcCtD
Nandrolone decanoate—Urticaria—Etidronic acid—osteoporosis	0.000244	0.0054	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Zoledronate—osteoporosis	0.000231	0.00512	CcSEcCtD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000227	0.0161	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000223	0.00493	CcSEcCtD
Nandrolone decanoate—Hypertension—Risedronate—osteoporosis	0.000222	0.00491	CcSEcCtD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000221	0.0157	CbGpPWpGaD
Nandrolone decanoate—Norethindrone—SHBG—osteoporosis	0.000219	0.0736	CrCbGaD
Nandrolone decanoate—MAOA—Oxidative Stress—SOD2—osteoporosis	0.000218	0.0155	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Etidronic acid—osteoporosis	0.000217	0.00481	CcSEcCtD
Nandrolone decanoate—Oedema—Ethinyl Estradiol—osteoporosis	0.000215	0.00476	CcSEcCtD
Nandrolone decanoate—Jaundice—Estradiol—osteoporosis	0.000215	0.00475	CcSEcCtD
Nandrolone decanoate—Hypertension—Pamidronate—osteoporosis	0.000211	0.00467	CcSEcCtD
Nandrolone decanoate—Urticaria—Estropipate—osteoporosis	0.000211	0.00467	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—VDR—osteoporosis	0.00021	0.0149	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000209	0.0148	CbGpPWpGaD
Nandrolone decanoate—MAOA—Oxidative Stress—GPX1—osteoporosis	0.000208	0.0148	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Alendronate—osteoporosis	0.000208	0.0046	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000208	0.0147	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—VDR—osteoporosis	0.000207	0.0147	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Ibandronate—osteoporosis	0.000203	0.00448	CcSEcCtD
Nandrolone decanoate—Oedema—Pamidronate—osteoporosis	0.0002	0.00441	CcSEcCtD
Nandrolone decanoate—Urticaria—Calcitriol—osteoporosis	0.000198	0.00438	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—CYP19A1—osteoporosis	0.000198	0.0667	CrCbGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—DKK1—osteoporosis	0.000198	0.014	CbGpPWpGaD
Nandrolone decanoate—Rash—Etidronic acid—osteoporosis	0.000194	0.00428	CcSEcCtD
Nandrolone decanoate—Dermatitis—Etidronic acid—osteoporosis	0.000194	0.00428	CcSEcCtD
Nandrolone decanoate—Hypertension—Zoledronate—osteoporosis	0.000193	0.00427	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—CYP27A1—osteoporosis	0.000192	0.0136	CbGpPWpGaD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00019	0.0134	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Estropipate—osteoporosis	0.000188	0.00416	CcSEcCtD
Nandrolone decanoate—CYP19A1—Endogenous sterols—POMC—osteoporosis	0.000185	0.0131	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Alendronate—osteoporosis	0.000185	0.00409	CcSEcCtD
Nandrolone decanoate—Nausea—Etidronic acid—osteoporosis	0.000183	0.00403	CcSEcCtD
Nandrolone decanoate—Oedema—Zoledronate—osteoporosis	0.000182	0.00403	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—ESR1—osteoporosis	0.000182	0.0614	CrCbGaD
Nandrolone decanoate—Pruritus—Ibandronate—osteoporosis	0.00018	0.00399	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Estradiol—osteoporosis	0.000178	0.00394	CcSEcCtD
Nandrolone decanoate—Pruritus—Calcitriol—osteoporosis	0.000177	0.0039	CcSEcCtD
Nandrolone decanoate—Oedema—Conjugated Estrogens—osteoporosis	0.000176	0.00388	CcSEcCtD
Nandrolone decanoate—Urticaria—Ethinyl Estradiol—osteoporosis	0.000171	0.00378	CcSEcCtD
Nandrolone decanoate—Rash—Estropipate—osteoporosis	0.000168	0.00371	CcSEcCtD
Nandrolone decanoate—Dermatitis—Estropipate—osteoporosis	0.000167	0.0037	CcSEcCtD
Nandrolone decanoate—Urticaria—Risedronate—osteoporosis	0.000167	0.00369	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000166	0.0117	CbGpPWpGaD
Nandrolone decanoate—Rash—Alendronate—osteoporosis	0.000165	0.00365	CcSEcCtD
Nandrolone decanoate—Dermatitis—Alendronate—osteoporosis	0.000165	0.00365	CcSEcCtD
Nandrolone decanoate—Rash—Raloxifene—osteoporosis	0.000162	0.00359	CcSEcCtD
Nandrolone decanoate—Dermatitis—Raloxifene—osteoporosis	0.000162	0.00359	CcSEcCtD
Nandrolone decanoate—Rash—Ibandronate—osteoporosis	0.000161	0.00355	CcSEcCtD
Nandrolone decanoate—Dermatitis—Ibandronate—osteoporosis	0.000161	0.00355	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—ESR1—osteoporosis	0.00016	0.0114	CbGpPWpGaD
Nandrolone decanoate—Nausea—Estropipate—osteoporosis	0.000158	0.00349	CcSEcCtD
Nandrolone decanoate—Rash—Calcitriol—osteoporosis	0.000157	0.00348	CcSEcCtD
Nandrolone decanoate—Dermatitis—Calcitriol—osteoporosis	0.000157	0.00347	CcSEcCtD
Nandrolone decanoate—Nausea—Alendronate—osteoporosis	0.000156	0.00344	CcSEcCtD
Nandrolone decanoate—Nausea—Raloxifene—osteoporosis	0.000153	0.00338	CcSEcCtD
Nandrolone decanoate—Pruritus—Ethinyl Estradiol—osteoporosis	0.000152	0.00337	CcSEcCtD
Nandrolone decanoate—Nausea—Ibandronate—osteoporosis	0.000151	0.00335	CcSEcCtD
Nandrolone decanoate—Hypertension—Estradiol—osteoporosis	0.000149	0.00329	CcSEcCtD
Nandrolone decanoate—Pruritus—Risedronate—osteoporosis	0.000149	0.00329	CcSEcCtD
Nandrolone decanoate—Nausea—Calcitriol—osteoporosis	0.000148	0.00328	CcSEcCtD
Nandrolone decanoate—Urticaria—Zoledronate—osteoporosis	0.000145	0.0032	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—ESR1—osteoporosis	0.000142	0.0101	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Pamidronate—osteoporosis	0.000141	0.00312	CcSEcCtD
Nandrolone decanoate—Oedema—Estradiol—osteoporosis	0.000141	0.00311	CcSEcCtD
Nandrolone decanoate—Urticaria—Conjugated Estrogens—osteoporosis	0.00014	0.00308	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.000139	0.00984	CbGpPWpGaD
Nandrolone decanoate—Rash—Ethinyl Estradiol—osteoporosis	0.000136	0.003	CcSEcCtD
Nandrolone decanoate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000136	0.003	CcSEcCtD
Nandrolone decanoate—Rash—Risedronate—osteoporosis	0.000132	0.00293	CcSEcCtD
Nandrolone decanoate—Dermatitis—Risedronate—osteoporosis	0.000132	0.00293	CcSEcCtD
Nandrolone decanoate—Pruritus—Zoledronate—osteoporosis	0.000129	0.00285	CcSEcCtD
Nandrolone decanoate—Nausea—Ethinyl Estradiol—osteoporosis	0.000128	0.00283	CcSEcCtD
Nandrolone decanoate—Progesterone—SHBG—osteoporosis	0.000127	0.0429	CrCbGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000127	0.00897	CbGpPWpGaD
Nandrolone decanoate—Rash—Pamidronate—osteoporosis	0.000126	0.00278	CcSEcCtD
Nandrolone decanoate—Dermatitis—Pamidronate—osteoporosis	0.000126	0.00278	CcSEcCtD
Nandrolone decanoate—Nausea—Risedronate—osteoporosis	0.000125	0.00276	CcSEcCtD
Nandrolone decanoate—Pruritus—Conjugated Estrogens—osteoporosis	0.000124	0.00275	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000123	0.00873	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000123	0.00872	CbGpPWpGaD
Nandrolone decanoate—Testosterone—SHBG—osteoporosis	0.000121	0.0406	CrCbGaD
Nandrolone decanoate—MAOA—Biological oxidations—CYP27A1—osteoporosis	0.00012	0.00853	CbGpPWpGaD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000119	0.00844	CbGpPWpGaD
Nandrolone decanoate—Nausea—Pamidronate—osteoporosis	0.000119	0.00262	CcSEcCtD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP27A1—osteoporosis	0.000117	0.00832	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000116	0.00821	CbGpPWpGaD
Nandrolone decanoate—Rash—Zoledronate—osteoporosis	0.000115	0.00254	CcSEcCtD
Nandrolone decanoate—Dermatitis—Zoledronate—osteoporosis	0.000115	0.00254	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.000114	0.00811	CbGpPWpGaD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000114	0.00808	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Estradiol—osteoporosis	0.000112	0.00247	CcSEcCtD
Nandrolone decanoate—Rash—Conjugated Estrogens—osteoporosis	0.000111	0.00245	CcSEcCtD
Nandrolone decanoate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000111	0.00245	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000109	0.0077	CbGpPWpGaD
Nandrolone decanoate—Nausea—Zoledronate—osteoporosis	0.000108	0.0024	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	0.000106	0.00751	CbGpPWpGaD
Nandrolone decanoate—Nausea—Conjugated Estrogens—osteoporosis	0.000104	0.00231	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000102	0.00723	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—CYP19A1—osteoporosis	0.000101	0.00714	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Estradiol—osteoporosis	9.95e-05	0.0022	CcSEcCtD
Nandrolone decanoate—Rash—Estradiol—osteoporosis	8.86e-05	0.00196	CcSEcCtD
Nandrolone decanoate—Dermatitis—Estradiol—osteoporosis	8.86e-05	0.00196	CcSEcCtD
Nandrolone decanoate—Testosterone—CYP19A1—osteoporosis	8.85e-05	0.0298	CrCbGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	8.74e-05	0.0062	CbGpPWpGaD
Nandrolone decanoate—Progesterone—ESR1—osteoporosis	8.61e-05	0.029	CrCbGaD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.6e-05	0.0061	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—ESR2—osteoporosis	8.53e-05	0.00605	CbGpPWpGaD
Nandrolone decanoate—Nausea—Estradiol—osteoporosis	8.35e-05	0.00185	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	7.95e-05	0.00564	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.85e-05	0.00556	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—ESR2—osteoporosis	7.53e-05	0.00534	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	7.44e-05	0.00527	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	7.26e-05	0.00514	CbGpPWpGaD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.15e-05	0.00507	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.98e-05	0.00495	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—CYP19A1—osteoporosis	6.32e-05	0.00448	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—POMC—osteoporosis	6.05e-05	0.00429	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.78e-05	0.0041	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PKM—osteoporosis	5.71e-05	0.00405	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—FDPS—osteoporosis	5.71e-05	0.00405	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.64e-05	0.004	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GPD2—osteoporosis	5.41e-05	0.00384	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PGLS—osteoporosis	5.41e-05	0.00384	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—ESR1—osteoporosis	5.31e-05	0.00377	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—IRS1—osteoporosis	4.96e-05	0.00352	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PNP—osteoporosis	4.95e-05	0.00351	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ATIC—osteoporosis	4.95e-05	0.00351	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—osteoporosis	4.59e-05	0.00326	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—ADCY5—osteoporosis	4.58e-05	0.00325	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—osteoporosis	4.57e-05	0.00324	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	4.55e-05	0.00322	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL6R—osteoporosis	4.54e-05	0.00322	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—U2AF1—osteoporosis	4.53e-05	0.00321	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.51e-05	0.0032	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.4e-05	0.00312	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	4.27e-05	0.00303	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CA2—osteoporosis	4.21e-05	0.00298	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—OXCT1—osteoporosis	4.21e-05	0.00298	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—MGLL—osteoporosis	4.1e-05	0.00291	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL6R—osteoporosis	4.01e-05	0.00284	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.83e-05	0.00272	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.81e-05	0.0027	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—POMC—osteoporosis	3.8e-05	0.00269	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—POMC—osteoporosis	3.71e-05	0.00263	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—ESR2—osteoporosis	3.6e-05	0.00256	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—FDPS—osteoporosis	3.58e-05	0.00254	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PKM—osteoporosis	3.58e-05	0.00254	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—ADCY5—osteoporosis	3.51e-05	0.00249	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PKM—osteoporosis	3.49e-05	0.00248	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—FDPS—osteoporosis	3.49e-05	0.00248	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—IDH2—osteoporosis	3.49e-05	0.00247	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL1B—osteoporosis	3.46e-05	0.00245	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GPD2—osteoporosis	3.4e-05	0.00241	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PGLS—osteoporosis	3.4e-05	0.00241	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—RPL24—osteoporosis	3.37e-05	0.00239	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PGLS—osteoporosis	3.31e-05	0.00235	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GPD2—osteoporosis	3.31e-05	0.00235	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP27A1—osteoporosis	3.28e-05	0.00233	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ACP5—osteoporosis	3.19e-05	0.00226	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ATIC—osteoporosis	3.11e-05	0.0022	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PNP—osteoporosis	3.11e-05	0.0022	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL1B—osteoporosis	3.05e-05	0.00216	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PNP—osteoporosis	3.03e-05	0.00215	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ATIC—osteoporosis	3.03e-05	0.00215	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TPI1—osteoporosis	2.97e-05	0.0021	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—VDR—osteoporosis	2.86e-05	0.00203	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—P4HB—osteoporosis	2.79e-05	0.00198	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MYC—osteoporosis	2.76e-05	0.00196	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GAPDH—osteoporosis	2.74e-05	0.00194	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—RAP1A—osteoporosis	2.67e-05	0.00189	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—OXCT1—osteoporosis	2.64e-05	0.00187	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CA2—osteoporosis	2.64e-05	0.00187	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—OXCT1—osteoporosis	2.58e-05	0.00183	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA2—osteoporosis	2.58e-05	0.00183	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MGLL—osteoporosis	2.57e-05	0.00182	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MGLL—osteoporosis	2.51e-05	0.00178	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TNF—osteoporosis	2.51e-05	0.00178	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—osteoporosis	2.38e-05	0.00169	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.29e-05	0.00162	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.28e-05	0.00162	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—osteoporosis	2.21e-05	0.00157	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—IDH2—osteoporosis	2.19e-05	0.00155	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—ESR1—osteoporosis	2.19e-05	0.00155	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ENO1—osteoporosis	2.15e-05	0.00153	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—IDH2—osteoporosis	2.13e-05	0.00151	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.13e-05	0.00151	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PSMA5—osteoporosis	2.12e-05	0.00151	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PSMA2—osteoporosis	2.12e-05	0.00151	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP27A1—osteoporosis	2.06e-05	0.00146	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL6—osteoporosis	2.02e-05	0.00143	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP27A1—osteoporosis	2.01e-05	0.00142	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ACP5—osteoporosis	2e-05	0.00142	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ACP5—osteoporosis	1.95e-05	0.00138	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PSMA5—osteoporosis	1.94e-05	0.00138	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PSMA2—osteoporosis	1.94e-05	0.00138	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.93e-05	0.00137	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TPI1—osteoporosis	1.86e-05	0.00132	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TPI1—osteoporosis	1.82e-05	0.00129	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL6—osteoporosis	1.78e-05	0.00127	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—P4HB—osteoporosis	1.75e-05	0.00124	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR2—osteoporosis	1.74e-05	0.00123	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP19A1—osteoporosis	1.72e-05	0.00122	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GAPDH—osteoporosis	1.72e-05	0.00122	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—P4HB—osteoporosis	1.71e-05	0.00121	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GAPDH—osteoporosis	1.68e-05	0.00119	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—RAP1A—osteoporosis	1.67e-05	0.00119	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—RAP1A—osteoporosis	1.63e-05	0.00116	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.42e-05	0.00101	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ADCY5—osteoporosis	1.41e-05	0.000998	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GPX1—osteoporosis	1.4e-05	0.000995	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—VDR—osteoporosis	1.38e-05	0.000977	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ENO1—osteoporosis	1.35e-05	0.000959	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PSMA2—osteoporosis	1.33e-05	0.000945	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PSMA5—osteoporosis	1.33e-05	0.000945	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ENO1—osteoporosis	1.32e-05	0.000935	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PSMA5—osteoporosis	1.3e-05	0.000921	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PSMA2—osteoporosis	1.3e-05	0.000921	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—MTHFR—osteoporosis	1.29e-05	0.000918	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—osteoporosis	1.14e-05	0.000806	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP19A1—osteoporosis	1.08e-05	0.000766	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR1—osteoporosis	1.05e-05	0.000746	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—POMC—osteoporosis	1.04e-05	0.000734	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ADCY5—osteoporosis	8.83e-06	0.000626	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GPX1—osteoporosis	8.8e-06	0.000624	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ADCY5—osteoporosis	8.61e-06	0.000611	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GPX1—osteoporosis	8.59e-06	0.000609	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MTHFR—osteoporosis	8.12e-06	0.000576	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MTHFR—osteoporosis	7.92e-06	0.000562	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—POMC—osteoporosis	6.5e-06	0.000461	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—POMC—osteoporosis	6.34e-06	0.000449	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—osteoporosis	5.47e-06	0.000388	CbGpPWpGaD
